Chicago Atlantic Real Estate Finance, Inc. (REFI) Q2 Earnings and Revenues Top Estimates — Positive

REFI   Zacks Investment Research — August 07, 2025

Chicago Atlantic Real Estate Finance, Inc. (REFI) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.5 per share a year ago.

image for news Chicago Atlantic Real Estate Finance, Inc. (REFI) Q2 Earnings and Revenues Top Estimates

Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates — Negative

RGNX   Zacks Investment Research — August 07, 2025

Regenxbio (RGNX) came out with a quarterly loss of $1.38 per share versus the Zacks Consensus Estimate of a loss of $1.13. This compares to a loss of $1.05 per share a year ago.

image for news Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates

Pagaya Technologies Ltd. (PGY) Lags Q2 Earnings Estimates — Negative

PGY   Zacks Investment Research — August 07, 2025

Pagaya Technologies Ltd. (PGY) came out with quarterly earnings of $0.64 per share, missing the Zacks Consensus Estimate of $0.69 per share.

image for news Pagaya Technologies Ltd. (PGY) Lags Q2 Earnings Estimates

Intel Stock Drops as Trump Says CEO 'Must Resign, Immediately' — Negative

INTC   Investopedia — August 07, 2025

Shares of Intel (INTC) fell in premarket trading Thursday after President Donald Trump called for new CEO Lip-Bu Tan's immediate resignation.

image for news Intel Stock Drops as Trump Says CEO 'Must Resign, Immediately'

Intel shares drop after Trump calls for CEO to resign immediately — Negative

INTC   CNBC Television — August 07, 2025

CNBC's Melissa Lee reports on the latest news.

image for news Intel shares drop after Trump calls for CEO to resign immediately

Why Upstart Stock Soared 26% in July — Positive

UPST   The Motley Fool — August 07, 2025

Upstart Holdings (UPST 3.89%) stock jumped 26% in July, according to data provided by S&P Global Market Intelligence. The market is getting excited about it again as interest rates come down, and many financial stocks have been reporting robust growth.

image for news Why Upstart Stock Soared 26% in July

FTQI: An Appealing Hedge For The Nasdaq-100 Index — Positive

FTQI   Seeking Alpha — August 07, 2025

FTQI offers a high 12% yield by writing covered calls on the Nasdaq-100, appealing to income-focused investors seeking equity exposure. The strategy limits upside potential but can outperform during flat or declining markets, making it a useful hedge or income alternative. Investors should be aware of higher fees, tracking error, and tax implications, as well as the capped returns from covered call writing.

image for news FTQI: An Appealing Hedge For The Nasdaq-100 Index

DraftKings Q2: Not As Strong As Financials Suggest — Positive

DKNG   Seeking Alpha — August 07, 2025

DraftKings Inc. reported very strong growth in Q2, sending the stock up. Underlying indicators don't signal such strength. Growth in betting handles and active users has slowed down, while favorable sports results drove up growth. DraftKings has maintained its market share rivalry with FanDuel in sports betting, but lost share in iGaming.

image for news DraftKings Q2: Not As Strong As Financials Suggest

Select Medical (SEM) Q2 2025 Earnings Transcript — Neutral

SEM   The Motley Fool — August 07, 2025

Image source: The Motley Fool.

image for news Select Medical (SEM) Q2 2025 Earnings Transcript

3 Big Winners From Trump's Shock 100% Semiconductor Tariffs — Positive

AAPL  NVDA  TSM   24/7 Wall Street — August 07, 2025

Key Points in This Article: President Trump's surprise 100% tariff on imported semiconductors announcement yesterday aims to boost U.S.

image for news 3 Big Winners From Trump's Shock 100% Semiconductor Tariffs

VIEW Lilly's obesity pill lags Novo's Wegovy injection in key trial — Negative

LLY  NVO   Reuters — August 07, 2025

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight after 72 weeks in a late-stage study, less than previous trial results for Novo Nordisk's injectable obesity treatment Wegovy.

image for news VIEW Lilly's obesity pill lags Novo's Wegovy injection in key trial

Options Corner: XYZ Earnings Ahead — Neutral

XYZ   Schwab Network — August 07, 2025

Block (XYZ) earnings are set to report later today. Shares are down 10% so far in 2025 and about 23% off of its 52-week highs.

image for news Options Corner: XYZ Earnings Ahead

Apple Jumps 5.1% After $100 Billion U.S. Manufacturing Pledge — Positive

AAPL   Zacks Investment Research — August 07, 2025

AAPL stock rises 5.1% after unveiling a $100 billion U.S. manufacturing pledge focused on chips, AI and advanced assembly.

image for news Apple Jumps 5.1% After $100 Billion U.S. Manufacturing Pledge

Barrick Mining to Post Q2 Earnings: What's in the Cards for the Stock? — Negative

B   Zacks Investment Research — August 07, 2025

Barrick Mining's Q2 results may reflect higher gold prices but face pressure from weaker output and increased costs.

image for news Barrick Mining to Post Q2 Earnings: What's in the Cards for the Stock?

e.l.f. Beauty Q1 Earnings Beat Estimates, Sales Rise 9% Y/Y — Positive

ELF   Zacks Investment Research — August 07, 2025

ELF posts fiscal first-quarter earnings beat with 9% sales growth and 210 bps market share gain, despite a dip in profit and margin pressure.

image for news e.l.f. Beauty Q1 Earnings Beat Estimates, Sales Rise 9% Y/Y

Energy Transfer Q2 Earnings In Line With Estimates, Revenues Down Y/Y — Neutral

ET   Zacks Investment Research — August 07, 2025

ET's second-quarter earnings and revenues decline year over year. Total costs and expenses decrease during the period.

image for news Energy Transfer Q2 Earnings In Line With Estimates, Revenues Down Y/Y

Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates — Positive

CROX   Zacks Investment Research — August 07, 2025

Crocs (CROX) came out with quarterly earnings of $4.23 per share, beating the Zacks Consensus Estimate of $4.01 per share. This compares to earnings of $4.01 per share a year ago.

image for news Crocs (CROX) Q2 Earnings and Revenues Surpass Estimates

Datadog (DDOG) Surpasses Q2 Earnings and Revenue Estimates — Positive

DDOG   Zacks Investment Research — August 07, 2025

Datadog (DDOG) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.43 per share a year ago.

image for news Datadog (DDOG) Surpasses Q2 Earnings and Revenue Estimates

C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates — Negative

CCCC   Zacks Investment Research — August 07, 2025

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.26 per share a year ago.

image for news C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates

Kimbell Royalty (KRP) Lags Q2 Earnings Estimates — Negative

KRP   Zacks Investment Research — August 07, 2025

Kimbell Royalty (KRP) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.11 per share a year ago.

image for news Kimbell Royalty (KRP) Lags Q2 Earnings Estimates